MolGlueDB: an online database of molecular glues
Nucleic Acids Research · 06.01.2026 · 54 (D1) · D1510-D1518
DOI: 10.1093/nar/gkaf811 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 21.08.2025. Verfasst von Xiao Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266003, …. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Databases, Chemical, Drug Discovery. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Shandong Province, Qingdao Science and Technology Demonstration Project, Qingdao Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Molecular glue degraders (MGDs) and proteolysis-targeting chimeras (PROTACs) are two prominent approaches in targeted protein degradation, both leveraging the ubiquitin-proteasome system to induce selective protein degradation. While PROTACs rely on heterobifunctional motifs, MGDs possess more compact, mono-affinitive molecular structures, offering distinct advantages in drug-like properties. Over the past decade, significant progress has been made in development of MGDs, with over 20 MGDs advancing through clinical trials. Despite these advancements, the field remains in its early stages due to the novel mode of action and complex design principles. To facilitate rational design of MGDs, we present MolGlueDB, an open-access, web-based database consolidating information from 241 publications (January 2001–May 2025). MolGlueDB contains 1840 entries, including 1629 distinct MGDs, 28 recruiting proteins, and 94 targets, with comprehensive data on chemical structures, binding affinities, degradation capacities, biological activities, and physicochemical properties. The platform supports both text-based and structure-based searches, enabling users to refine results based on specific molecular attributes. MolGlueDB is freely accessible at https://www.molgluedb.com, providing a valuable resource for advancing research of MGDs and accelerating drug discovery in the field of targeted protein degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266003, China.
- Center for Targeted Protein Degradation and Drug Discovery, Ocean University of China, Qingdao, Shandong 266003, China.
- Marine Biomedical Research Institute of Qingdao, Qingdao, Shandong 266071, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao, Shandong 266137, China.
Förderung
- Key Research and Development Program of Shandong Province
- Qingdao Science and Technology Demonstration Project
- Qingdao Municipal Science and Technology Bureau
- Key Technology Research and Industrialization Demonstration Projects of Qingdao
Zitieren
APA
Wang, X., Zhuang, Z., Zhang, C., Zhang, B., Zhan, W., Wang, Y., Liu, Z., Yuan, S., Niu, W., He, Q., Tian, Y., Xu, X., Fang, S., & Qin, C. (2026). MolGlueDB: an online database of molecular glues. Nucleic Acids Research, 54(D1), D1510-D1518. https://doi.org/10.1093/nar/gkaf811
Vancouver
Wang X, Zhuang Z, Zhang C, Zhang B, Zhan W, Wang Y, et al. MolGlueDB: an online database of molecular glues. Nucleic Acids Research. 2026;54(D1):D1510-D1518. doi:10.1093/nar/gkaf811
BibTeX
@article{Wang2026,
author = {Wang, Xiao and Zhuang, Zhiyao and Zhang, Chengwei and Zhang, Bowen and Zhan, Wei and Wang, Yifan and Liu, Zhaojuan and Yuan, Shanwen and Niu, Wenjia and He, Qi and Tian, Yanqing and Xu, Ximing and Fang, Senbiao and Qin, Chong},
title = {MolGlueDB: an online database of molecular glues},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {D1},
pages = {D1510--D1518},
doi = {10.1093/nar/gkaf811}
}
EUVIMED